Guru Ownership Trend
Guru Analysis for Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $27.36 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $7.59 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 54.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Myriad Genetics, Inc. (MYGN)
Major holders include Steven Cohen ($13.91 M), Cliff Asness ($5.44 M), Renaissance Technologies (RenTech) ($1.05 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 5.01 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.59 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited MYGN. The total reported sell value was $6.49 M.
Yes, 1 managers opened new positions in MYGN, and 4 increased their existing holdings. The total reported buy value was $14.08 M.